Sodium channel protein type 9 subunit alpha (Nav1.7), Sodium channel protein type 8 subunit alpha (Nav1.8), and Sodium channel protein type 10 subunit alpha (Nav1.9) (Nav1.7, Nav1.8, Nav1.9)

Peripheral nociceptor sodium channels refer to a subset of voltage-gated sodium channels (VGSCs), principally Nav1.7, Nav1.8, and Nav1.9, which are predominantly expressed in the peripheral nervous system’s nociceptors—sensory neurons responsible for detecting painful stimuli[1][2][3][4][6]. These channels mediate the fast influx of sodium ions that underlies the generation and conduction of action potentials in response to tissue-damaging or noxious stimuli, thus playing a crucial role in pain signal transmission[1][3][5]. Gain-of-function mutations in these channels (especially Nav1.7, encoded by SCN9A) are directly linked to inherited pain syndromes, while loss-of-function leads to congenital insensitivity to pain[2][4]. These channels are essential therapeutic targets for the development of analgesics due to their defined roles in pain; isoform-specific blockade is an active area of drug development for both acute and chronic pain management, as fewer adverse effects are expected from selectively targeting nociceptor-expressed channels compared to pan-sodium channel inhibition[1][6].

Other names

Voltage-gated sodium channel alpha subunits Nav1.7 (SCN9A), Nav1.8 (SCN10A), Nav1.9 (SCN11A)peripheral nociceptor sodium channelsnociceptor sodium channelsVGSCs (in nociceptors)

Blockade of sodium influx through channel, inhibiting action potential generation/conduction Isoform-selective blockade to modulate pain transmission specifically through nociceptor-expressed sodium channels